🇺🇸 FDA
Patent

US 9453078

Modified antibody compositions, methods of making and using thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9453078 (Modified antibody compositions, methods of making and using thereof) held by CytomX Therapeutics, Inc. expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K47/6845